Rodino-Klapac Louise 4

What Happened
Louise Rodino-Klapac, President of R&D and Technical Operations at Sarepta Therapeutics (SRPT), disposed of 948 shares on March 11, 2026. The shares were withheld by the company to satisfy tax withholding obligations related to restricted stock units; the withholding value was $16,144 (price used: $17.03 per share). This was a routine tax-withholding disposition rather than an open-market sale.

Key Details

• Transaction date and price: 2026-03-11 at $17.03 per share.
• Shares involved: 948 shares withheld/disposed; total value $16,144.
• Transaction code: F — shares withheld to satisfy tax obligations.
• Footnote: F1 — shares were withheld to satisfy tax withholding on RSUs granted March 10, 2025.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Filing: Form 4 filed 2026-03-13 (filed two days after the transaction, within the typical two-business-day Form 4 window).

Context
This was a cashless tax-withholding event tied to RSU vesting, a routine corporate action that does not necessarily indicate insider sentiment. For retail investors, tax withholding dispositions are common and generally less informative than voluntary open-market buys or sales.